1. Home
  2. PSQH vs EVAX Comparison

PSQH vs EVAX Comparison

Compare PSQH & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PSQ Holdings Inc.

PSQH

PSQ Holdings Inc.

HOLD

Current Price

$5.48

Market Cap

29.3M

ML Signal

HOLD

Logo Evaxion Biotech

EVAX

Evaxion Biotech

HOLD

Current Price

$3.32

Market Cap

29.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PSQH
EVAX
Founded
2021
2008
Country
United States
Denmark
Employees
N/A
N/A
Industry
Advertising
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
29.3M
29.7M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
PSQH
EVAX
Price
$5.48
$3.32
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
★ $11.67
AVG Volume (30 Days)
42.8K
★ 50.5K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 55.00
N/A
EPS
N/A
★ N/A
Revenue
★ $5,685,987.00
N/A
Revenue This Year
$80.20
N/A
Revenue Next Year
$34.74
$328.20
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 1096.61
N/A
52 Week Low
$0.36
$2.77
52 Week High
$6.94
$12.15

Technical Indicators

Market Signals
Indicator
PSQH
EVAX
Relative Strength Index (RSI) 55.95 55.96
Support Level $4.71 $2.92
Resistance Level $5.71 $3.33
Average True Range (ATR) 0.32 0.15
MACD -0.04 0.02
Stochastic Oscillator 63.46 74.29

Price Performance

Historical Comparison
PSQH
EVAX

About PSQH PSQ Holdings Inc.

PSQ Holdings Inc operates the website and mobile application named as PublicSq. It is an app and website that connects freedom-loving Americans to high-quality businesses that share values, both online and in local communities. It has three reportable segments comprised of Marketplace; which includes a marketplace platform to access consumers that are drawn to patriotic values and the revenue is generated in the form of advertising and eCommerce transactions, and Brands segment in which through its wholly-owned brand, the company generates revenue from online sales of diapers and wipes and third financial technology which assists consumers, lenders, and retailers in offering point-of-sale financing products.

About EVAX Evaxion Biotech

Evaxion AS is a clinical-stage TechBio company developing novel vaccines with its proprietary, clinically validated and scalable AI platform, AI-Immunology. The platform harnesses the power of artificial intelligence to decode the human immune system and develop novel vaccine candidates for cancer and infectious diseases for patients in the market. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing inventive and targeted treatment options.

Share on Social Networks: